Incidence and factors associated with adverse drug reactions in a cohort of individuals starting dolutegravir or efavirenz . RSD [Internet]. 2022 Mar. 28 [cited 2025 Dec. 5];11(4):e0811426250. Available from: https://rsdjournal.org/rsd/article/view/26250